Van Damme P, Dewil M, Robberecht W, Van Den Bosch L
Neurobiology, Campus Gasthuisberg, Leuven, Belgium.
Neurodegener Dis. 2005;2(3-4):147-59. doi: 10.1159/000089620.
Since its description by Charcot more than 130 years ago, the pathogenesis of selective motor neuron degeneration in amyotrophic lateral sclerosis (ALS) remains unsolved. Over the years, many pathogenic mechanisms have been proposed. Amongst others these include: oxidative stress, excitotoxicity, aggregate formation, inflammation, growth factor deficiency and neurofilament disorganization. This multitude of contributing factors indicates that ALS is a complex disease and also suggests that ALS is a multifactorial disorder. Excitotoxicity is not the newest and most spectacular hypothesis in the ALS field, but it is undoubtedly one of the most robust pathogenic mechanisms supported by an impressive amount of evidence. Moreover, the therapeutic efficacy of riluzole, the only drug proven to slow disease progression in ALS, is most likely related to its anti-excitotoxic properties. In this review, we will give an overview of the arguments in favor of the involvement of excitotoxicity in ALS and of the possible mechanisms leading to motor neuron death. We will also summarize the intrinsic properties of motor neurons that render these cells particularly vulnerable to excitotoxicity and could explain the selective vulnerability of motor neurons in ALS. All this information could help to develop new and better therapeutic strategies that could protect motor neurons from excitotoxicity.
自130多年前夏科氏(Charcot)对肌萎缩侧索硬化症(ALS)进行描述以来,其选择性运动神经元变性的发病机制仍未得到解决。多年来,人们提出了许多致病机制。其中包括:氧化应激、兴奋性毒性、聚集体形成、炎症、生长因子缺乏和神经丝紊乱。众多促成因素表明ALS是一种复杂疾病,也提示ALS是一种多因素疾病。兴奋性毒性并非ALS领域最新颖、最引人注目的假说,但无疑是有大量证据支持的最有力的致病机制之一。此外,利鲁唑是唯一被证实可延缓ALS疾病进展的药物,其治疗效果很可能与其抗兴奋性毒性特性有关。在本综述中,我们将概述支持兴奋性毒性参与ALS的论据以及导致运动神经元死亡的可能机制。我们还将总结运动神经元的内在特性,这些特性使这些细胞特别易受兴奋性毒性影响,并可解释ALS中运动神经元的选择性易损性。所有这些信息有助于开发新的、更好的治疗策略,从而保护运动神经元免受兴奋性毒性影响。